Nath Bio-Genes Financials
NSE: NATHBIOGEN | BSE: 537291
₹153.12
As on 04-Sep-2026 15:52IST
Market cap
₹290 Cr
Revenue (TTM)
₹490 Cr
P/E Ratio
7.9
P/B Ratio
0.4
Div. Yield
1.3 %
Income Statement (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
489.81
|
364.91
|
332.62
|
301.36
|
278.36
|
137.70
|
|||||
|
Total Income
|
497.75
|
369.45
|
333.25
|
301.92
|
280.22
|
138.28
|
|||||
|
Total Expenditure
|
440.50
|
314.95
|
282.67
|
252.38
|
241.14
|
117.80
|
|||||
|
EBITDA
|
49.31
|
49.96
|
49.96
|
48.98
|
37.22
|
19.90
|
|||||
|
Depreciation
|
3.99
|
3.82
|
3.26
|
3.01
|
3.08
|
4.51
|
|||||
|
EBIT
|
45.31
|
46.15
|
46.69
|
45.97
|
34.14
|
15.39
|
|||||
|
Interest
|
17.06
|
10.65
|
9.20
|
10.36
|
10.64
|
3.67
|
|||||
|
Other Income
|
7.95
|
4.55
|
0.63
|
0.55
|
1.85
|
0.58
|
|||||
|
Exceptional Items
|
5.14
|
0.54
|
3.45
|
--
|
-88.78
|
--
|
|||||
|
Profit before Tax
|
41.35
|
40.58
|
41.56
|
36.16
|
-63.43
|
12.30
|
|||||
|
Provision for Tax
|
4.74
|
1.98
|
1.95
|
1.15
|
3.95
|
0.55
|
|||||
|
Profit after Tax
|
36.61
|
38.60
|
39.62
|
35.01
|
-67.39
|
11.75
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Share of Associate
|
--
|
--
|
--
|
0.02
|
0.00
|
--
|
|||||
|
Consolidated Profit
|
36.61
|
38.60
|
39.62
|
35.03
|
-67.38
|
11.75
|
Liabilities (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
680.46
|
644.39
|
609.92
|
573.17
|
541.93
|
57.47
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
0.00
|
--
|
|||||
|
Non-Current Liabilities
|
22.27
|
16.52
|
7.87
|
3.19
|
3.28
|
1.79
|
|||||
|
Current Liabilities
|
394.70
|
365.30
|
262.45
|
216.43
|
194.29
|
98.12
|
|||||
|
Total Liabilities
|
1,097.42
|
1,026.21
|
880.23
|
792.80
|
739.49
|
158.28
|
Assets (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
275.92
|
336.20
|
308.57
|
272.97
|
271.72
|
37.63
|
|||||
|
Current Assets
|
778.86
|
690.01
|
571.66
|
519.83
|
467.77
|
119.75
|
|||||
|
Total Assets
|
1,097.42
|
1,026.21
|
880.23
|
792.80
|
739.49
|
158.28
|
|||||
|
Total Debt*
|
--
|
122.50
|
110.35
|
105.21
|
92.96
|
19.25
|
|||||
|
Net Current Assets
|
384.17
|
324.71
|
309.22
|
303.40
|
273.48
|
21.63
|
|||||
|
Contingent Liabilities
|
--
|
89.31
|
92.40
|
71.85
|
60.59
|
0.34
|
Cashflow (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
17.58
|
74.59
|
38.37
|
17.05
|
14.21
|
|||||
|
Cash Flow from Investing Activities
|
--
|
-3.96
|
-27.40
|
-2.88
|
-19.85
|
-20.77
|
|||||
|
Cash from Financing Activities
|
--
|
-2.13
|
-7.78
|
-1.67
|
-22.23
|
5.74
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
11.49
|
39.41
|
33.81
|
-25.04
|
-0.81
|
Financials Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
17.74
|
20.31
|
20.85
|
18.43
|
-35.46
|
--
|
|||||
|
Cash EPS (₹)
|
19.26
|
22.32
|
22.56
|
20.01
|
-33.84
|
10.16
|
|||||
|
Adjusted Book Value (₹)
|
375.04
|
339.08
|
320.94
|
301.61
|
285.16
|
--
|
|||||
|
Dividend per Share (₹)
|
1.31
|
2.00
|
2.00
|
2.00
|
2.00
|
--
|
|||||
|
Cash Flow per Share (₹)
|
--
|
9.25
|
39.25
|
20.19
|
8.97
|
8.88
|
|||||
|
Free Cash Flow per Share (₹)
|
--
|
-0.24
|
20.63
|
13.50
|
-44.38
|
-6.76
|
Profitability Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
6.89
|
7.26
|
7.09
|
-14.84
|
23.88
|
|||||
|
ROE (%)
|
4.96
|
6.15
|
6.70
|
6.28
|
-22.48
|
22.76
|
|||||
|
ROA (%)
|
3.45
|
4.05
|
4.74
|
4.57
|
-15.03
|
8.50
|
|||||
|
EBIT Margin (%)
|
9.25
|
12.65
|
14.04
|
15.25
|
12.26
|
11.18
|
|||||
|
Net Margin (%)
|
7.36
|
10.45
|
11.89
|
11.60
|
-24.05
|
8.49
|
|||||
|
Cash Profit Margin (%)
|
--
|
11.62
|
12.89
|
12.62
|
-23.10
|
11.80
|
Growth Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
21.02
|
9.71
|
10.37
|
8.26
|
102.15
|
11.13
|
|||||
|
EBIT Growth (%)
|
17.44
|
-1.17
|
1.58
|
34.66
|
--
|
54.30
|
|||||
|
Net Profit Growth (%)
|
18.02
|
-2.57
|
13.16
|
151.96
|
-673.70
|
27.66
|
|||||
|
EPS Growth (%)
|
23.02
|
-2.57
|
13.11
|
151.98
|
-583.10
|
--
|
|||||
|
Book Value Growth (%)
|
--
|
5.65
|
6.41
|
5.77
|
842.91
|
25.69
|
Valuation Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
7.92
|
7.18
|
8.33
|
7.69
|
--
|
--
|
|||||
|
Price / Book Value
|
0.41
|
0.43
|
0.54
|
0.47
|
0.75
|
--
|
|||||
|
Dividend Yield (%)
|
1.31
|
1.37
|
1.15
|
1.41
|
0.94
|
--
|
|||||
|
EV/EBITDA
|
6.16
|
5.70
|
7.18
|
6.79
|
12.65
|
1.60
|
|||||
|
Close Price (₹)
|
164.77
|
145.85
|
174.05
|
141.25
|
213.35
|
--
|
|||||
|
High Price (₹)
|
238.69
|
264.50
|
244.60
|
261.90
|
474.70
|
--
|
|||||
|
Low Price (₹)
|
126.15
|
137.55
|
139.05
|
128.30
|
191.85
|
--
|
|||||
|
Market Cap (₹ Cr)
|
289.91
|
277.18
|
330.20
|
269.30
|
405.46
|
--
|
Solvency Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.03
|
0.19
|
0.18
|
0.18
|
0.17
|
0.33
|
|||||
|
Short term debt to equity ratio
|
--
|
0.17
|
0.17
|
0.18
|
0.17
|
0.30
|
|||||
|
Current Ratio
|
1.97
|
1.89
|
2.18
|
2.40
|
2.41
|
1.22
|
|||||
|
Quick Ratio
|
0.83
|
0.96
|
1.30
|
1.44
|
1.27
|
0.43
|
|||||
|
Interest Coverage
|
3.42
|
4.81
|
5.52
|
4.49
|
-4.96
|
4.35
|
Operating Efficiency Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
17.44
|
24.36
|
28.35
|
32.29
|
30.73
|
15.24
|
|||||
|
Asset Turnover
|
0.46
|
0.38
|
0.40
|
0.39
|
0.62
|
1.00
|
|||||
|
Receivable days
|
--
|
91.63
|
105.14
|
110.74
|
69.85
|
44.32
|
|||||
|
Inventory Days
|
--
|
284.23
|
240.40
|
259.30
|
195.06
|
189.43
|
|||||
|
Payable days
|
--
|
-249.00
|
-1,457.17
|
744.29
|
1,503.38
|
-4,219.16
|
|||||
|
Cash Conversion Cycle
|
--
|
624.86
|
1,802.71
|
-374.25
|
-1,238.47
|
4,452.91
|